COMPANY

Oricula Therapeutics LLC

HQ: Seattle, WA source · oricularx.com ↗ · West Coast

Keywords: hearing drug-induced hearing loss

Location: Seattle, WA · source · Apr 22, 2020

Profile checked Oct 10, 2026

NIH awards 3

Annual award amounts. Total $2.2M.

Jan 11, 2017 NIH award 5R44AI122428-03 FY2017: $1,116,932 awarded for that fiscal year; activity R44 (SBIR); PI GLESER, MALCOLM; recipient as written: ORICULA THERAPEUTICS, LLC, SEATTLE, WA. Novel therapeutic agent to prevent hea source ↗
Jan 11, 2016 NIH award 9R44AI122428-02A1 FY2016: $946,196 awarded for that fiscal year; activity R44 (SBIR); PI GLESER, MALCOLM; recipient as written: ORICULA THERAPEUTICS, LLC, SEATTLE, WA. Novel therapeutic agent to prevent hea source ↗
Mar 31, 2014 NIH award 1R43DC013930-01 FY2014: $169,398 awarded for that fiscal year; activity R43 (SBIR); PI GLESER, MALCOLM; recipient as written: ORICULA THERAPEUTICS, LLC, SEATTLE, WA. New compounds to protect hearing during source ↗